Validating the Rett Syndrome Gross Motor Scale

Rett syndrome is a pervasive neurodevelopmental disorder associated with a pathogenic mutation on the MECP2 gene. Impaired movement is a fundamental component and the Rett Syndrome Gross Motor Scale was developed to measure gross motor abilities in this population. The current study investigated the validity and reliability of the Rett Syndrome Gross Motor Scale. Video data showing gross motor abilities supplemented with parent report data was collected for 255 girls and women registered with the Australian Rett Syndrome Database, and the factor structure and relationships between motor scores, age and genotype were investigated. Clinical assessment scores for 38 girls and women with Rett syndrome who attended the Danish Center for Rett Syndrome were used to assess consistency of measurement. Principal components analysis enabled the calculation of three factor scores: Sitting, Standing and Walking, and Challenge. Motor scores were poorer with increasing age and those with the p.Arg133Cys, p.Arg294* or p.Arg306Cys mutation achieved higher scores than those with a large deletion. The repeatability of clinical assessment was excellent (intraclass correlation coefficient for total score 0.99, 95% CI 0.93–0.98). The standard error of measurement for the total score was 2 points and we would be 95% confident that a change 4 points in the 45-point scale would be greater than within-subject measurement error. The Rett Syndrome Gross Motor Scale could be an appropriate measure of gross motor skills in clinical practice and clinical trials.

[1]  D. Cadman,et al.  THE GROSS MOTOR FUNCTION MEASURE: A MEANS TO EVALUATE THE EFFECTS OF PHYSICAL THERAPY , 1989, Developmental medicine and child neurology.

[2]  H. Zoghbi,et al.  Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome , 2001, Brain & development (Tokyo. 1979).

[3]  P. Raina,et al.  Rasch analysis of the Gross Motor Function Measure: validating the assumptions of the Rasch model to create an interval-level measure. , 2003, Archives of physical medicine and rehabilitation.

[4]  H. Leonard,et al.  The phenotype associated with a large deletion on MECP2 , 2012, European Journal of Human Genetics.

[5]  H. Leonard,et al.  Twenty years of surveillance in Rett syndrome: what does this tell us? , 2014, Orphanet Journal of Rare Diseases.

[6]  W. Kaufmann,et al.  Investigating genotype–phenotype relationships in Rett syndrome using an international data set , 2008, Neurology.

[7]  B. Hagberg Clinical manifestations and stages of Rett syndrome. , 2002, Mental retardation and developmental disabilities research reviews.

[8]  Peter Humphreys Measuring gross motor activities in Rett syndrome , 2015, Developmental medicine and child neurology.

[9]  J. Weir Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. , 2005, Journal of strength and conditioning research.

[10]  Pieter M. Kroonenberg,et al.  Missing data in principal component analysis of questionnaire data: a comparison of methods , 2014 .

[11]  Leslie G. Portney Dpt PhD Fapta,et al.  Foundations of Clinical Research: Applications to Practice , 2015 .

[12]  H. Zoghbi,et al.  Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome , 2008, Neurology.

[13]  W. Kaufmann,et al.  Gross motor profile in rett syndrome as determined by video analysis. , 2008, Neuropediatrics.

[14]  W. Kaufmann,et al.  Development of a Video-based Evaluation Tool in Rett Syndrome , 2007, Journal of autism and developmental disorders.

[15]  Kathleen Kelly,et al.  The Gross Motor Function Measure: A Means to Evaluate the Effects of Physical Therapy , 1992 .

[16]  H. Leonard,et al.  Altered Attainment of Developmental Milestones Influences the Age of Diagnosis of Rett Syndrome , 2011, Journal of child neurology.

[17]  W. Kaufmann,et al.  Rett syndrome: Revised diagnostic criteria and nomenclature , 2010, Annals of neurology.

[18]  H. Leonard,et al.  Trends in the Diagnosis of Rett Syndrome in Australia , 2011, Pediatric Research.

[19]  W. Kaufmann,et al.  Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome , 2014, Journal of Medical Genetics.

[20]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[21]  W. Kaufmann,et al.  Change in Gross Motor Abilities of Girls and Women With Rett Syndrome Over a 3- to 4-Year Period , 2011, Journal of child neurology.